Legacy Advisors, LLC Bio Techne Corp Transaction History

Legacy Advisors, LLC

$978 Million
Q4 2024

A detailed history of Legacy Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Legacy Advisors, LLC holds 14,279 shares of TECH stock, worth $941,557. This represents 0.11% of its overall portfolio holdings.

Number of Shares

14,279

Previous 12,781 11.72%

Holding current value

$941,557

Previous $1.02 Million 0.69%

% of portfolio

0.11%

Previous 0.11%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$66.37 - $78.17 $99,422 - $117,098	1,498 Added 11.72%	14,279 $1.03 Million
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $35,267 - $40,927	-497 Reduced 3.74%	12,781 $1.02 Million
Q2 2024 Jul 30, 2024	BUY	$62.12 - $84.15 $17,766 - $24,066	286 Added 2.2%	13,278 $951,000
Q1 2024 Apr 30, 2024	BUY	$65.98 - $77.09 $139,085 - $162,505	2,108 Added 19.37%	12,992 $914,000
Q4 2023 Feb 12, 2024	BUY	$52.83 - $78.22 $67,780 - $100,356	1,283 Added 13.36%	10,884 $839,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $42,200 - $55,887	625 Added 6.96%	9,601 $653,000
Q2 2023 Jul 20, 2023	BUY	$73.76 - $85.98 $33,634 - $39,206	456 Added 5.35%	8,976 $732,000
Q1 2023 May 01, 2023	BUY	$71.62 - $86.62 $43,258 - $52,318	604 Added 7.63%	8,520 $632,000
Q4 2022 Feb 01, 2023	BUY	$80.67 - $352.29 $529,275 - $2.31 Million	6,561 Added 484.21%	7,916 $656,000
Q3 2022 Nov 09, 2022	BUY	$282.54 - $391.85 $94,650 - $131,269	335 Added 32.84%	1,355 $385,000
Q2 2022 Jul 25, 2022	BUY	$322.67 - $449.65 $109,062 - $151,981	338 Added 49.56%	1,020 $354,000
Q1 2022 May 11, 2022	BUY	$353.85 - $487.79 $241,325 - $332,672	682 New	682 $295,000

Others Institutions Holding TECH

# of Institutions

616

Shares Held

156M

Call Options Held

200K

Put Options Held

15.3K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.

Account

Legacy Advisors, LLC Bio Techne Corp Transaction History